On Friday October 19th, the State of Nevada completed their final inspection of the first 5,000 sq. ft facility which is designated to the Company’s Phenofarm Cultivation Licence. All permitting is complete for this licence and the final approval now allows for the immediate transition of plants to the new facility to complete their cycle and provide first harvest.
The Company’s second 5,000 sq. ft facility, designated to the Econevada Cultivation and Processing Licences is pending final kitchen and equipment inspection.
“We are thrilled to announce the completion of the first building of our flagship cannabis facilities in North Las Vegas, which has a potential build-out to 300,000 sq. ft. Marapharm is open for business! We are positioned to be a long-term winner in this Las Vegas market.” Linda Sampson, President and CEO
ABOUT MARAPHARM VENTURES INC.
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQX® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQX® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators